Predictors of pulmonary function at 6 years of age in infants with bronchopulmonary dysplasia.
FEV1
bronchopulmonary dysplasia
growth
pulmonary function testing
socioeconomic status
Journal
Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
revised:
01
12
2020
received:
09
10
2020
accepted:
18
12
2020
pubmed:
16
2
2021
medline:
21
10
2021
entrez:
15
2
2021
Statut:
ppublish
Résumé
Bronchopulmonary dysplasia (BPD) is a major complication of premature birth and the most common cause of chronic lung disease in infancy. Previous studies have shown that children with a history of BPD have impaired lung function in childhood compared to their term counterparts. However, little is known about potential modifiable factors that alter lung function trajectories and subsequent respiratory morbidity in this population. To identify potential modifiable risk factors for the development of impaired lung function in patients with a history of prematurity and bronchopulmonary dysplasia. Growth parameters (birth, 2 years old, 6 years old) and pulmonary function testing (6 years old) were retrospectively reviewed for subjects (n = 598) recruited from an outpatient BPD clinic who were born ≤36 weeks gestation and were ≥5 years of age. Of the 598 recruited subjects, 88 (14.7%) performed adequate pulmonary function testing at approximately 6 years of age. The mean forced expiratory volume in 1 s global lung initiative (GLI) Z-score was -1.31 with lower values associated with Nissen fundoplication. The mean forced vital capacity GLI Z-score was -0.72 with lower values associated with higher amounts of oxygen required at time of initial hospital discharge and Nissen fundoplication. Our study found that children with BPD have lower predicted lung function values. Although growth parameters at age 2 and 6 years did not correlate with lung function values at 6 years of age; use and greater requirement for supplemental oxygen and the presence of a Nissen fundoplication at discharge were associated with lower lung function. Prospective studies should focus on identifying modifiable risk factors that could minimize the impact of BPD on later lung function.
Identifiants
pubmed: 33587822
doi: 10.1002/ppul.25244
pmc: PMC8035215
mid: NIHMS1674342
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
974-981Subventions
Organisme : NIEHS NIH HHS
ID : P30 ES013508
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL114800
Pays : United States
Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
J Pediatr. 2017 Feb;181:12-28.e1
pubmed: 27908648
Thorax. 2013 Aug;68(8):760-6
pubmed: 23604458
J Pediatr. 2005 Apr;146(4):469-73
pubmed: 15812448
Natl Vital Stat Rep. 2020 Jul;69(7):1-18
pubmed: 32730740
Lancet Respir Med. 2018 Jul;6(7):535-544
pubmed: 29628376
Eur Respir J. 2011 May;37(5):1199-207
pubmed: 20947682
N Engl J Med. 2017 Jul 27;377(4):329-337
pubmed: 28745986
Am J Respir Crit Care Med. 2010 Jul 15;182(2):237-45
pubmed: 20378729
Am J Respir Cell Mol Biol. 2001 Aug;25(2):150-5
pubmed: 11509323
J Pediatr. 2014 Jan;164(1):40-45.e4
pubmed: 24055328
Ann Am Thorac Soc. 2018 May;15(5):530-538
pubmed: 29328889
NCHS Data Brief. 2019 Jul;(346):1-8
pubmed: 31442195
BMC Pediatr. 2003 Jul 8;3:6
pubmed: 12848901
Lancet. 2012 Jun 9;379(9832):2162-72
pubmed: 22682464
Am J Respir Crit Care Med. 2001 Jun;163(7):1723-9
pubmed: 11401896
Lancet. 2015 Jan 31;385(9966):430-40
pubmed: 25280870
Pediatr Pulmonol. 2016 Oct;51(10):1057-1064
pubmed: 27077215
Can Respir J. 2011 Sep-Oct;18(5):265-70
pubmed: 21969927
Lancet Child Adolesc Health. 2018 May;2(5):350-359
pubmed: 30169268
Thorax. 1997 Sep;52(9):820-7
pubmed: 9371217
Pediatr Pulmonol. 2014 Feb;49(2):173-8
pubmed: 23804596
Thorax. 1982 Aug;37(8):564-71
pubmed: 7179184
Breathe (Sheff). 2017 Sep;13(3):e56-e64
pubmed: 28955406
Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88
pubmed: 31613151